Health news
28.07.21

BMJ Practice Pointer: Mask related acne (“maskne”) and other facial dermatoses

What you need to know:
  • Not all facial dermatoses related to personal protective equipment are “maskne”
  • Irritant contact dermatitis is the most common cause
  • Maintenance of the skin barrier and regular “mask breaks” are important aspects of management, in addition to standard medical treatment of the skin condition
Read BMJ Practice Pointer...
Further content in BMJ...
20.07.21

Whole of population-based cohort study of recovery time from COVID-19 in NSW

COVID-19 results in persisting symptoms but there is little systematically collected data estimating recovery time following infection. The authors followed 94% of all COVID-19 cases (n=2904) diagnosed in NSW between January and May 2020 using 3-4 weekly telephone interviews and linkage to hospitalisation and death data to determine if they had recovered from COVID-19 based on symptom resolution. 80% of those with COVID-19 recovered within a month, and 5% continued to experience symptoms 3 months later.
Read more...
12.07.21

Practice Changing Update: Triple therapy for children ≥6 years with cystic fibrosis

Elexacaftor-tezacaftor-ivacaftor is an important therapy for most patients with cystic fibrosis, but its use has been limited to adolescents and adults. This new Practice Changing Update from UpToDate recommends triple therapy (elexacaftor-tezacaftor-ivacaftor) rather than dual therapy (tezacaftor-ivacaftor or lumacaftor-ivacaftor) for patients ≥6 years old with cystic fibrosis who are homozygous for the F508del variant. (Grade 1B recommendation)

UpToDate Cystic fibrosis: treatment with CFTR modulators...
Read original article...
11.06.21

NEW REVIEW: Neurology and neuropsychiatry of COVID-19

This systematic review and meta-analysis aims to describe the characteristics of the early literature and estimate point prevalence for neurological and neuropsychiatric manifestations of infection with SARS-CoV-2. 13,292 records were screened to identify 215 included studies from 30 countries. Neurological and neuropsychiatric symptoms of COVID-19 in the pandemic’s early phase are varied and common. Symptoms with the highest prevalence were anosmia, weakness, fatigue, dysgeusia, myalgia, depression, headache, anxiety and altered mental status. Heterogeneity for most clinical manifestations was high.
Read article...

Previous health news

Due to budget constraints the Library Service hasn’t been able to renew the following subscriptions for 2021.

  • Age and ageing (OUP)
  • Annals of the rheumatic diseases (BMJ)
  • Archives of disease in childhood (BMJ)
  • BJR: British journal of radiology (Wiley)
  • BMJ Case reports
  • BMJ Evidence-based medicine
  • BMJ Supportive & palliative care
  • British journal of anaesthesia (Elsevier)
  • Chest (Elsevier)
  • Clinical infectious diseases (OUP)
  • European heart journal (OUP)
  • Evidence based nursing (BMJ)
  • Heart (BMJ)
  • International journal of gynecological cancer (BMJ)
  • Joint Commission Journal on quality and patient safety (Elsevier)
  • Journal of clinical pathology (BMJ)
  • Journal of medical ethics (BMJ)
  • Journal of medical genetics (BMJ)
  • Journal of neurology, neurosurgery & psychiatry (BMJ)
  • Journal of oral and maxillofacial surgery (Elsevier)
  • Journal of telemedicine and telecare (Sage)
  • Journal of the American College of Cardiology (Elsevier)
  • Journal of the National Cancer Institute (OUP)
  • Journal of thoracic and cardiovascular surgery (Elsevier)
  • The Lancet Diabetes & endocrinology (Elsevier)
  • Postgraduate medical journal (BMJ)
  • Regional anesthesia & pain management (BMJ)
  • Rheumatology (OUP)
  • Schizophrenia bulletin (OUP)
  • Seminars in fetal and neonatal medicine (Elsevier)
  • Sleep (OUP)
  • Thorax (BMJ)